What is Elixir Research Group?
Elixir Research Group is dedicated to advancing medical innovation by providing exceptional care for clinical trial subjects. The company focuses on ensuring that protocol requirements are met, timelines are adhered to, and recruitment goals are achieved for its sponsors. By maintaining long-lasting partnerships, Elixir Research Group aims to be a pivotal player in the development of new pharmaceuticals, biotechnology advancements, and medical devices. Its strategic location within a major medical hub in Houston further enhances its operational capabilities and access to a vast network of healthcare resources.
How much funding has Elixir Research Group raised?
Elixir Research Group has raised a total of $57K across 1 funding round:
Debt
$57K
Debt (2021): $57K with participation from PPP
Key Investors in Elixir Research Group
PPP
Public-Private Partnership
What's next for Elixir Research Group?
With significant Series B/C stage funding, Elixir Research Group is poised for accelerated growth and enhanced operational capacity. The recent capital injection is expected to fuel strategic initiatives, potentially including the expansion of clinical trial services, investment in advanced research technologies, and the broadening of its market reach. This financial backing will likely enable Elixir Research Group to undertake more complex and larger-scale clinical studies, further solidifying its role as a key partner for pharmaceutical and biotech companies seeking to bring novel treatments and devices to market.
See full Elixir Research Group company page
